酵素結合免疫吸附檢測法市場規模、佔有率、成長分析（按產品類型、應用、技術、最終用戶和地區）- 2025 年至 2032 年產業預測

預計 2023 年全球酵素結合免疫吸附檢測法市場價值將達到 24 億美元，並從 2024 年的 25 億美元成長到 2032 年的 35 億美元，預測期內（2025-2032 年）的複合年成長率為 5.1%。

由於慢性病和感染疾病的流行、檢測技術的進步以及在藥物研發和食品安全領域的廣泛應用，全球酵素結合免疫吸附檢測法(ELISA) 市場正在經歷顯著成長。 ELISA 能夠準確定量抗原和抗體，這使得它在不斷發展的以預防為主的醫療環境中能夠及時診斷和介入。此外，它在疫苗研發和品管中的關鍵作用也使其在製藥公司中的重要性日益凸顯。此外，在人工智慧、機器學習和物聯網 (IoT) 的整合推動下，市場也正在經歷變革時期，這些技術提高了診斷的準確性和實驗室的效率。這些技術確保 ELISA 在不斷發展的診斷環境中始終是不可或缺的尖端工具，滿足了人們對可靠結果日益成長的需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 主要和次要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 使用案例

酵素結合免疫吸附檢測法市場規模（依產品類型及複合年成長率） (2025-2032)

• 市場概覽
• 套件
• 試劑
• 裝置

酵素結合免疫吸附檢測法市場規模：依應用及複合年成長率（2025-2032）

• 市場概覽
• 臨床診斷
• 研究
• 獸醫
• 其他

酵素結合免疫吸附檢測法市場規模：依技術及複合年成長率（2025-2032）

• 市場概覽
• 夾心 ELISA
• 間接酵素連結免疫吸附試驗
• 競爭性 ELISA
• 直接 ELISA

酵素結合免疫吸附檢測法市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 診斷實驗室
• 研究所
• 其他

酵素結合免疫吸附檢測法市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

    主要企業簡介

    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Abcam plc
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • R&D Systems, Inc.
    • Enzo Life Sciences, Inc.
    • Ortho Clinical Diagnostics
    • BioLegend, Inc.
    • RayBIoTech, Inc.
    • QIAGEN NV
    • GenScript BIoTech Corporation

結論和建議

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.4 Billion in 2023 and is poised to grow from 2.5 USD Billion in 2024 to USD 3.5 Billion by 2032, growing at a CAGR of 5.1% in the forecast period (2025-2032).

The global enzyme-linked immunosorbent assay (ELISA) market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technologies, and a broader range of applications in drug discovery and food safety. ELISA's precision in quantifying antigens and antibodies enhances its appeal for timely diagnosis and intervention in an evolving healthcare landscape focusing on prevention. Furthermore, its vital role in vaccine development and quality control bolsters its relevance among pharmaceutical organizations. The market is also undergoing transformation through the integration of artificial intelligence, machine learning, and IoT, which improve diagnostic accuracy and laboratory efficiency. These technologies ensure ELISA remains an indispensable, cutting-edge tool in the evolving diagnostic landscape, catering to rising demand for reliable results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

A key market driver for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market is the increasing prevalence of chronic diseases and the rising demand for accurate diagnostic tools. As healthcare systems worldwide strive for improved disease management and early detection, ELISA techniques are gaining prominence due to their sensitivity, specificity, and versatility in detecting a range of biomarkers. This trend is further amplified by advancements in biotechnology and pharmaceuticals, which are driving research and development of novel assays. Additionally, the growing emphasis on personalized medicine and preventive healthcare is propelling the demand for ELISA tests in clinical and research settings.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

One of the key market restraints for the global enzyme-linked immunosorbent assay (ELISA) market is the high cost associated with advanced ELISA diagnostic kits and necessary laboratory equipment. These expenses can limit accessibility for smaller laboratories and healthcare facilities, especially in developing regions where budget constraints are more pronounced. Additionally, the complexity of ELISA procedures may require specialized training for personnel, further compounding costs and contributing to the potential inefficiencies in workflow. As a result, these financial and logistical challenges may hinder the widespread adoption of ELISA technologies, impacting market growth and innovation.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is witnessing a significant trend towards the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating advanced automated ELISA analyzers, which enhance efficiency by automating processes such as plate loading, reagent dispensing, and result reporting. This automation mitigates human error and accelerates turnaround times, making it particularly advantageous in high-demand contexts like pharmaceutical research and vaccine development, where processing large volumes of samples swiftly is essential. This shift towards automation is poised to transform ELISA applications, contributing to improved diagnostics and research outcomes across various sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Kits
• Reagents
• Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Research
• Veterinary
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sandwich ELISA
• Indirect ELISA
• Competitive ELISA
• Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations